HEADER TRANSCRIPTION REGULATOR 19-NOV-07 3BEJ TITLE STRUCTURE OF HUMAN FXR IN COMPLEX WITH MFA-1 AND CO-ACTIVATOR PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BILE ACID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 249-486; COMPND 5 SYNONYM: FARNESOID X-ACTIVATED RECEPTOR, FARNESOL RECEPTOR HRR-1, COMPND 6 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4, RETINOID X RECEPTOR- COMPND 7 INTERACTING PROTEIN 14, RXR-INTERACTING PROTEIN 14; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 11 CHAIN: E, F; COMPND 12 FRAGMENT: RESIDUES 676-700; COMPND 13 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 14 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H4, BAR, FXR, HRR1, RIP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-KG; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: NCOA1, SRC1; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-KG KEYWDS FXR, BAR, NR1H4, BILE ACID RECEPTOR, NHR, NUCLEAR RECEPTOR, KEYWDS 2 ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, KEYWDS 3 NUCLEUS, REPRESSOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, KEYWDS 4 ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, KEYWDS 5 PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, TRANSFERASE, UBL KEYWDS 6 CONJUGATION, TRANSCRIPTION-TRANSFERASE COMPLEX, TRANSCRIPTION KEYWDS 7 REGULATOR EXPDTA X-RAY DIFFRACTION AUTHOR S.M.SOISSON,G.PARTHASARATHY,J.W.BECKER REVDAT 7 21-FEB-24 3BEJ 1 REMARK REVDAT 6 31-JUL-19 3BEJ 1 COMPND REMARK REVDAT 5 24-JAN-18 3BEJ 1 AUTHOR REVDAT 4 25-OCT-17 3BEJ 1 REMARK REVDAT 3 24-FEB-09 3BEJ 1 VERSN REVDAT 2 29-APR-08 3BEJ 1 JRNL REVDAT 1 18-MAR-08 3BEJ 0 JRNL AUTH S.M.SOISSON,G.PARTHASARATHY,A.D.ADAMS,S.SAHOO,A.SITLANI, JRNL AUTH 2 C.SPARROW,J.CUI,J.W.BECKER JRNL TITL IDENTIFICATION OF A POTENT SYNTHETIC FXR AGONIST WITH AN JRNL TITL 2 UNEXPECTED MODE OF BINDING AND ACTIVATION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 5337 2008 JRNL REFN ISSN 0027-8424 JRNL PMID 18391212 JRNL DOI 10.1073/PNAS.0710981105 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 41792 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.01 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.35 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6106 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2240 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5809 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.86 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 297 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3923 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 362 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.86200 REMARK 3 B22 (A**2) : 1.68300 REMARK 3 B33 (A**2) : 5.17900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4096 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 5522 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 874 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 129 ; 8.000 ; NULL REMARK 3 GENERAL PLANES : 610 ; 8.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 4026 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 169 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.27 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BEJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045420. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98793, 0.97931, 0.97907, REMARK 200 0.96863 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41792 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.57700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-22% PEG3350, 0.1M BIS-TRIS, 4 MM REMARK 280 YCL(3), 0.2M AMMONIUM ACETATE, 1 MM DTT. PROTEIN WAS REMARK 280 CARBOXYMETHYLATED WITH IODOACETIC ACID, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.82100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.82550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.44450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.82550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.82100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.44450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 235 REMARK 465 THR A 236 REMARK 465 LYS A 237 REMARK 465 SER A 238 REMARK 465 CYS A 239 REMARK 465 ARG A 240 REMARK 465 GLU A 241 REMARK 465 LYS A 242 REMARK 465 THR A 243 REMARK 465 GLU A 244 REMARK 465 LEU A 340 REMARK 465 PRO A 341 REMARK 465 SER A 342 REMARK 465 GLN A 472 REMARK 465 THR B 235 REMARK 465 THR B 236 REMARK 465 LYS B 237 REMARK 465 SER B 238 REMARK 465 CYS B 239 REMARK 465 ARG B 240 REMARK 465 GLU B 241 REMARK 465 LYS B 242 REMARK 465 THR B 243 REMARK 465 GLN B 472 REMARK 465 CYS E 676 REMARK 465 PRO E 677 REMARK 465 SER E 678 REMARK 465 SER E 679 REMARK 465 HIS E 680 REMARK 465 SER E 681 REMARK 465 SER E 682 REMARK 465 LEU E 683 REMARK 465 THR E 684 REMARK 465 GLU E 696 REMARK 465 GLY E 697 REMARK 465 SER E 698 REMARK 465 PRO E 699 REMARK 465 SER E 700 REMARK 465 CYS F 676 REMARK 465 PRO F 677 REMARK 465 SER F 678 REMARK 465 SER F 679 REMARK 465 HIS F 680 REMARK 465 SER F 681 REMARK 465 SER F 682 REMARK 465 LEU F 683 REMARK 465 GLU F 696 REMARK 465 GLY F 697 REMARK 465 SER F 698 REMARK 465 PRO F 699 REMARK 465 SER F 700 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 Y YT3 A 1 O HOH A 603 1.93 REMARK 500 O HOH B 590 O HOH B 774 2.01 REMARK 500 Y YT3 B 2 O HOH B 765 2.12 REMARK 500 O HOH A 514 O HOH A 615 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 309 27.97 -67.68 REMARK 500 ASP A 312 105.56 -46.85 REMARK 500 HIS A 313 51.47 -50.18 REMARK 500 GLU A 314 -36.13 -171.94 REMARK 500 HIS A 344 -52.07 66.20 REMARK 500 LEU A 391 36.67 -83.34 REMARK 500 TYR A 397 34.96 -90.70 REMARK 500 GLN A 423 58.41 -146.89 REMARK 500 PHE A 461 -79.12 -84.59 REMARK 500 THR A 462 145.99 160.92 REMARK 500 LEU B 391 41.73 -86.08 REMARK 500 HIS B 422 -179.49 167.30 REMARK 500 GLN B 423 -118.73 -78.44 REMARK 500 GLU B 425 -71.02 132.12 REMARK 500 ASN B 426 82.86 45.22 REMARK 500 ASP B 470 56.72 35.76 REMARK 500 ARG E 686 -49.06 93.04 REMARK 500 ARG E 692 -91.13 -53.82 REMARK 500 LEU E 693 -7.85 -44.45 REMARK 500 GLU F 685 110.73 -33.13 REMARK 500 ARG F 686 -35.22 68.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 715 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH B 721 DISTANCE = 7.09 ANGSTROMS REMARK 525 HOH B 730 DISTANCE = 7.12 ANGSTROMS REMARK 525 HOH B 756 DISTANCE = 9.19 ANGSTROMS REMARK 525 HOH B 761 DISTANCE = 5.96 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MUF A 473 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MUF B 1 DBREF 3BEJ A 235 472 UNP Q96RI1 NR1H4_HUMAN 249 486 DBREF 3BEJ B 235 472 UNP Q96RI1 NR1H4_HUMAN 249 486 DBREF 3BEJ E 676 700 UNP Q15788 NCOA1_HUMAN 676 700 DBREF 3BEJ F 676 700 UNP Q15788 NCOA1_HUMAN 676 700 SEQRES 1 A 238 THR THR LYS SER CYS ARG GLU LYS THR GLU LEU THR PRO SEQRES 2 A 238 ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SER TYR SEQRES 3 A 238 ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN LYS ILE SEQRES 4 A 238 LEU LYS GLU GLU PHE SER ALA GLU GLU ASN PHE LEU ILE SEQRES 5 A 238 LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL LEU VAL SEQRES 6 A 238 GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR LEU ASP SEQRES 7 A 238 HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER ALA VAL SEQRES 8 A 238 GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE ASN LYS SEQRES 9 A 238 LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU GLU ARG SEQRES 10 A 238 ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE THR PRO SEQRES 11 A 238 MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU LYS MET SEQRES 12 A 238 THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE VAL ILE SEQRES 13 A 238 LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG GLU ALA SEQRES 14 A 238 VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL LEU GLN SEQRES 15 A 238 LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO GLN HIS SEQRES 16 A 238 PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU ARG THR SEQRES 17 A 238 PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER TRP ARG SEQRES 18 A 238 VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS GLU ILE SEQRES 19 A 238 TRP ASP VAL GLN SEQRES 1 B 238 THR THR LYS SER CYS ARG GLU LYS THR GLU LEU THR PRO SEQRES 2 B 238 ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SER TYR SEQRES 3 B 238 ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN LYS ILE SEQRES 4 B 238 LEU LYS GLU GLU PHE SER ALA GLU GLU ASN PHE LEU ILE SEQRES 5 B 238 LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL LEU VAL SEQRES 6 B 238 GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR LEU ASP SEQRES 7 B 238 HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER ALA VAL SEQRES 8 B 238 GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE ASN LYS SEQRES 9 B 238 LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU GLU ARG SEQRES 10 B 238 ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE THR PRO SEQRES 11 B 238 MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU LYS MET SEQRES 12 B 238 THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE VAL ILE SEQRES 13 B 238 LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG GLU ALA SEQRES 14 B 238 VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL LEU GLN SEQRES 15 B 238 LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO GLN HIS SEQRES 16 B 238 PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU ARG THR SEQRES 17 B 238 PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER TRP ARG SEQRES 18 B 238 VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS GLU ILE SEQRES 19 B 238 TRP ASP VAL GLN SEQRES 1 E 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 E 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 F 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 F 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER HET YT3 A 1 1 HET MUF A 473 31 HET YT3 B 2 1 HET MUF B 1 31 HETNAM YT3 YTTRIUM (III) ION HETNAM MUF (8ALPHA,10ALPHA,13ALPHA,17BETA)-17-[(4-HYDROXYPHENYL) HETNAM 2 MUF CARBONYL]ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID FORMUL 5 YT3 2(Y 3+) FORMUL 6 MUF 2(C27 H32 O4) FORMUL 9 HOH *362(H2 O) HELIX 1 1 THR A 246 ASN A 261 1 16 HELIX 2 2 PRO A 266 GLU A 276 1 11 HELIX 3 3 SER A 279 LEU A 305 1 27 HELIX 4 4 GLY A 307 LEU A 311 5 5 HELIX 5 5 GLU A 314 LYS A 339 1 26 HELIX 6 6 HIS A 344 ARG A 353 1 10 HELIX 7 7 SER A 358 GLU A 374 1 17 HELIX 8 8 THR A 378 LEU A 391 1 14 HELIX 9 9 ASP A 400 GLN A 423 1 24 HELIX 10 10 GLN A 428 THR A 442 1 15 HELIX 11 11 THR A 442 ASN A 457 1 16 HELIX 12 12 THR A 462 ASP A 470 1 9 HELIX 13 13 THR B 246 TYR B 260 1 15 HELIX 14 14 PRO B 266 GLU B 276 1 11 HELIX 15 15 SER B 279 LYS B 304 1 26 HELIX 16 16 GLY B 307 LEU B 311 5 5 HELIX 17 17 ASP B 312 ASN B 337 1 26 HELIX 18 18 SER B 345 ARG B 353 1 9 HELIX 19 19 SER B 358 LEU B 375 1 18 HELIX 20 20 THR B 378 LEU B 391 1 14 HELIX 21 21 ASP B 400 LYS B 420 1 21 HELIX 22 22 GLN B 428 ASN B 457 1 30 HELIX 23 23 THR B 462 TRP B 469 1 8 HELIX 24 24 HIS E 687 LEU E 694 1 8 HELIX 25 25 HIS F 687 GLN F 695 1 9 CISPEP 1 LEU B 340 PRO B 341 0 -2.46 CISPEP 2 GLU E 685 ARG E 686 0 7.81 CISPEP 3 GLU F 685 ARG F 686 0 -2.18 SITE 1 AC1 8 ASP A 359 GLU A 360 HOH A 474 HOH A 475 SITE 2 AC1 8 HOH A 499 HOH A 514 HOH A 603 HOH B 734 SITE 1 AC2 8 HOH A 603 ASP B 359 GLU B 360 HOH B 569 SITE 2 AC2 8 HOH B 576 HOH B 590 HOH B 734 HOH B 765 SITE 1 AC3 17 MET A 265 PHE A 284 LEU A 287 THR A 288 SITE 2 AC3 17 MET A 290 MET A 328 ARG A 331 SER A 332 SITE 3 AC3 17 ILE A 335 LEU A 348 HIS A 447 TRP A 454 SITE 4 AC3 17 PHE A 461 TRP A 469 HOH A 485 HOH A 508 SITE 5 AC3 17 HOH A 570 SITE 1 AC4 17 MET B 265 PHE B 284 LEU B 287 THR B 288 SITE 2 AC4 17 MET B 328 PHE B 329 ARG B 331 SER B 332 SITE 3 AC4 17 ILE B 335 HIS B 447 MET B 450 TRP B 454 SITE 4 AC4 17 PHE B 461 TRP B 469 HOH B 595 HOH B 623 SITE 5 AC4 17 HOH B 733 CRYST1 41.642 90.889 129.651 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024014 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011002 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007713 0.00000